You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ)業績快報:2020年度淨利潤降31.04%至1.17億元
格隆匯 02-03 16:27

格隆匯 2 月 3日丨華森製藥(002907.SZ)披露2020年度業績快報,實現營業總收入8.83億元,同比增長4.82%;營業利潤1.35億元,同比下降31.77%;利潤總額1.35億元,同比下降31.88%;歸屬於上市公司股東的淨利潤1.17億元,同比下降31.04%;基本每股收益0.2920元。

業績下降的主要原因主要是:①公司受新冠肺炎疫情影響,部分品種市場終端銷量受到影響,整體銷售收入增速放緩;②因公司加速創新升級進程,研發費用進一步大比例增加;③部分產品納入國家組織藥品集中採購後價格下降導致毛利率下降;第五期新建GMP生產基地項目(“五期項目”)陸續投入使用並開始折舊、計提可轉換公司債券利息和股權激勵費用而導致大量非現金性費用增加。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account